Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Morphine + bupivacaine** is an intrathecal postoperative analgesic co-administration regimen evaluated by Indiana University in patients undergoing elective laparoscopic colorectal surgery. The protocol administers preservative-free morphine, an opioid analgesic, together with hyperbaric bupivacaine, a long-acting local anesthetic, into cerebrospinal fluid before surgery. Morphine activates mu-opioid receptors to suppress nociceptive transmission, while bupivacaine blocks voltage-gated sodium channels to inhibit neuronal impulse conduction and provide spinal anesthesia and analgesia. The regimen was studied against an erector spinae plane block for postoperative pain control. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05257941))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on morphine + bupivacaine (Indiana University).